Henaff Louise, Dumolard Laure, Bura Vinod, Sume Gerald Etapelong, Ndiaye Sidy, Sanwogou Jennifer, Cho Heeyoun, Hombach Joachim, Steffen Christoph A
World Health Organization (WHO), 1211 Geneva, Switzerland.
World Health Organization (WHO) Regional Office for South-East Asia, New Delhi 110002, India.
Vaccines (Basel). 2025 Jan 17;13(1):80. doi: 10.3390/vaccines13010080.
Well-functioning National Immunization Technical Advisory Groups (NITAGs) are valuable contributors to decision-making processes in the complex immunization policy arena. This paper describes the progress made globally on the establishment and strengthening of these key advisory groups and discusses some of their strengths, challenges, and opportunities.
The data submitted annually by countries to the World Health Organization (WHO) via the WHO/UNICEF Joint Reporting Form (JRF) were analyzed, comparing the NITAG functionality criteria in 2012 and 2023.
In 2023 and 2012, 88% and 61% of countries, respectively, reported having a NITAG. A total of 77% of NITAGs met all six NITAG process criteria in 2023 compared to 33% in 2012. This progress was most notable in the WHO African Region, increasing from 7% (2012) to 77% (2023), and the South-East Asia Region, increasing from 45% (2012) to 91% (2023). In 2023, 84% of NITAGs issued a vaccine-policy recommendation that was adopted by decision-makers.
Marked progress has been made since 2012 on establishing and maintaining NITAGs, with a small number of countries yet to form an advisory committee. Supporting and sustaining NITAG functions remains an important means for countries to foster independent and transparent expert advice on vaccine and immunization policy. Setbacks in countries facing instability or political turmoil are a reminder of the reversibility of progress. WHO and partners play an important role in supporting countries in strengthening these advisory committees. Continuous commitment by countries to the function and involvement of NITAGs in policy recommendations is essential for enhancing the strength and resilience of immunization programs.
运作良好的国家免疫技术咨询小组（NITAGs）是复杂免疫政策领域决策过程的重要贡献者。本文描述了全球在建立和加强这些关键咨询小组方面取得的进展，并讨论了它们的一些优势、挑战和机遇。
分析各国每年通过世界卫生组织（WHO）/联合国儿童基金会联合报告表（JRF）提交给WHO的数据，比较2012年和2023年NITAG功能标准。
2023年和2012年分别有88%和61%的国家报告设有NITAG。2023年共有77%的NITAG符合所有六项NITAG流程标准，而2012年这一比例为33%。这一进展在WHO非洲区域最为显著，从2012年的7%增至2023年的77%，在东南亚区域也很明显，从2012年的45%增至2023年的91%。2023年，84%的NITAG发布了决策者采纳的疫苗政策建议。
自2012年以来，在建立和维持NITAG方面取得了显著进展，仍有少数国家尚未组建咨询委员会。支持和维持NITAG的职能仍然是各国获得关于疫苗和免疫政策的独立和透明专家建议的重要手段。面临不稳定或政治动荡国家的挫折提醒人们进展可能会逆转。WHO及其合作伙伴在支持各国加强这些咨询委员会方面发挥着重要作用。各国持续致力于NITAG的职能以及让其参与政策建议，对于增强免疫规划的实力和恢复力至关重要。
